Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.55%15.1B | -0.21%3.58B | 4.75%4.12B | 5.78%14.44B | 2.30%3.74B | 0.69%3.19B | 5.40%3.59B | 14.52%3.93B | 4.74%13.65B | -0.39%3.65B |
Cost of revenue | 2.60%10.71B | 3.78%2.57B | 5.15%2.45B | 13.29%10.44B | 12.30%2.68B | 21.50%2.96B | 10.52%2.48B | 7.99%2.33B | 5.09%9.22B | 6.03%2.39B |
Gross profit | 9.63%4.38B | -9.08%1.01B | 4.17%1.67B | -9.83%4B | -16.53%1.06B | -68.66%228.83M | -4.44%1.11B | 25.60%1.6B | 4.00%4.44B | -10.58%1.27B |
Operating expense | 8.19%873.51M | -1.37%233.16M | 10.98%212.82M | 3.58%807.35M | 7.51%186.43M | 3.94%192.74M | -2.63%236.41M | 7.83%191.77M | 3.11%779.48M | 3.03%173.41M |
Staff costs | 4.93%353.56M | ---- | ---- | 1.59%336.94M | ---- | ---- | ---- | ---- | 1.51%331.66M | ---- |
Selling and administrative expenses | 21.80%212.72M | ---- | ---- | -12.19%174.64M | ---- | ---- | ---- | ---- | 0.57%198.87M | ---- |
-Selling and marketing expense | 2.06%115.69M | ---- | ---- | -15.40%113.36M | ---- | ---- | ---- | ---- | -5.93%134M | ---- |
-General and administrative expense | 58.33%97.03M | ---- | ---- | -5.55%61.28M | ---- | ---- | ---- | ---- | 17.31%64.88M | ---- |
Depreciation and amortization | -3.52%20.75M | ---- | ---- | -0.19%21.51M | ---- | ---- | ---- | ---- | 4.70%21.55M | ---- |
-Depreciation | -3.52%20.75M | ---- | ---- | -0.19%21.51M | ---- | ---- | ---- | ---- | 4.70%21.55M | ---- |
Other operating expenses | 4.45%286.47M | ---- | ---- | 20.61%274.27M | ---- | ---- | ---- | ---- | 7.83%227.4M | ---- |
Operating profit | 10.00%3.51B | -11.16%778.84M | 3.24%1.45B | -12.69%3.19B | -20.35%870.87M | -93.37%36.09M | -4.91%876.71M | 28.48%1.41B | 4.20%3.66B | -12.41%1.09B |
Net non-operating interest income (expenses) | 89.77%-53K | 37.50%-80K | 30.52%-107K | 40.39%-518K | -106K | 31.94%-130K | 58.17%-128K | 58.60%-154K | 69.56%-869K | 0 |
Non-operating interest income | 811.11%328K | 42.86%20K | 100.00%4K | 44.00%36K | 41.67%17K | 200.00%3K | 27.27%14K | 100.00%2K | -3.85%25K | 33.33%12K |
Non-operating interest expense | -31.23%381K | -29.58%100K | -28.85%111K | -38.03%554K | 925.00%123K | -30.73%133K | -55.21%142K | -58.18%156K | -68.97%894K | -97.23%12K |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -118.18%-6.59M | 36.26M | 0 | 0 | 0 | |||||
Less:Other special charges | ---- | ---- | ---- | ---36.26M | --0 | ---- | ---- | ---- | ---- | ---- |
Less:Write off | --6.59M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | 58.53%52.61M | 57.59%22.11M | 79.99%21.5M | -54.62%33.19M | 9.27%20.57M | -300.10%-13.36M | -55.65%14.03M | -25.33%11.94M | -15.78%73.14M | 26.36%18.82M |
Income before tax | 9.08%3.56B | -10.08%800.87M | 3.89%1.48B | -12.53%3.26B | -19.85%891.32M | -89.32%58.86M | -6.58%890.61M | 27.74%1.42B | 3.77%3.73B | -11.93%1.11B |
Income tax | 22.53%1.05B | -9.78%250.43M | 4.37%460.32M | -26.56%855.95M | -67.57%113.69M | -86.36%23.66M | -6.42%277.57M | 27.86%441.04M | 3.88%1.17B | -11.30%350.58M |
Net income | 4.29%2.51B | -10.21%550.44M | 3.68%1.02B | -6.15%2.41B | 2.11%777.64M | -90.68%35.2M | -6.65%613.05M | 27.68%979.43M | 3.72%2.56B | -12.21%761.55M |
Net income continuous operations | 4.29%2.51B | -10.21%550.44M | 3.68%1.02B | -6.15%2.41B | 2.11%777.64M | -90.68%35.2M | -6.65%613.05M | 27.68%979.43M | 3.72%2.56B | -12.21%761.55M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 4.29%2.51B | -10.21%550.44M | 3.68%1.02B | -6.15%2.41B | 2.11%777.64M | -90.68%35.2M | -6.65%613.05M | 27.68%979.43M | 3.72%2.56B | -12.21%761.55M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 4.29%2.51B | -10.21%550.44M | 3.68%1.02B | -6.15%2.41B | 2.11%777.64M | -90.68%35.2M | -6.65%613.05M | 27.68%979.43M | 3.72%2.56B | -12.21%761.55M |
Gross dividend payment | ||||||||||
Basic earnings per share | 6.78%155.59 | -7.83%34 | 5.66%62.37 | -6.16%145.71 | 2.99%47.5 | -89.99%2.29 | -7.29%36.89 | 27.00%59.03 | 3.71%155.27 | -12.25%46.12 |
Diluted earnings per share | 6.78%155.59 | -7.85%33.9957 | 5.66%62.37 | -6.16%145.71 | 3.49%47.5 | -90.57%2.1578 | -7.29%36.89 | 27.00%59.03 | 3.71%155.27 | -12.67%45.897 |
Dividend per share | 6.94%77 | 54.17%37 | 0 | 56.52%72 | 108.70%48 | 0 | 4.35%24 | 0 | 15.00%46 | 15.00%23 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |